Vorinostat Plus FND in Relapsed or Refractory Mantle Cell Lymphoma
Clinical trial NCT01578343 · TERMINATED
Trial details
- NCT number
- NCT01578343
- Sponsor
- Samsung Medical Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2015-09-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.